tiprankstipranks
GT Biopharma (DE:OXI)
FRANKFURT:OXI

GT Biopharma (OXI) Balance Sheet

0 Followers

GT Biopharma Balance Sheet

GT Biopharma's total assets for Q2 2023 were $18.14M, a decrease of -9.90% from the previous quarter. DE:OXI total liabilities were $6.38M for the fiscal quarter, a -9.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 16.74M$ 32.43M$ 5.66M$ 396.00K$ 25.40M
Total Liabilities
$ 5.00M$ 10.26M$ 35.09M$ 19.71M$ 14.03M
Total Equity Gross Minority
$ 11.73M$ 21.91M$ -29.43M$ -19.31M$ 11.37M
Total Capitalization
$ 11.73M$ 21.91M$ -29.43M$ -19.14M$ 11.54M
Preferred Stock Equity
--$ 3.00K$ 3.00K$ 2.00K
Capital Lease Obligations
--$ 0.00$ 120.00K-
Currency in USD

GT Biopharma Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis